The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124130723 12413072 3 F 20150409 20160920 20160527 20160929 EXP US-BAYER-2015-141559 BAYER 82.00 YR E F Y 0.00000 20160929 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124130723 12413072 1 PS NEXAVAR SORAFENIB 1 Oral 200 MG, QD Y 21923 200 MG FILM-COATED TABLET QD
124130723 12413072 2 SS NEXAVAR SORAFENIB 1 Oral 400 MG DAILY Y 21923 400 MG FILM-COATED TABLET
124130723 12413072 3 SS NEXAVAR SORAFENIB 1 Oral 200 MG, BID Y 21923 200 MG FILM-COATED TABLET BID
124130723 12413072 4 SS NEXAVAR SORAFENIB 1 Oral 200 MG, QD, EXCEPT ON WEDNESDAY AND SUNDAY Y 21923 200 MG FILM-COATED TABLET QD
124130723 12413072 5 SS NEXAVAR SORAFENIB 1 Oral 400 MG, QD Y 21923 400 MG FILM-COATED TABLET QD
124130723 12413072 6 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 0
124130723 12413072 7 C METOPROLOL. METOPROLOL 1 0
124130723 12413072 8 C SIMVASTATINE SIMVASTATIN 1 0
124130723 12413072 9 C GLIMEPIRIDE. GLIMEPIRIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124130723 12413072 1 Soft tissue sarcoma
124130723 12413072 2 Soft tissue sarcoma
124130723 12413072 3 Soft tissue sarcoma
124130723 12413072 4 Soft tissue sarcoma
124130723 12413072 5 Soft tissue sarcoma
124130723 12413072 6 Blood pressure increased
124130723 12413072 7 Blood pressure increased
124130723 12413072 8 Blood cholesterol increased
124130723 12413072 9 Blood glucose increased

Outcome of event

Event ID CASEID OUTC COD
124130723 12413072 HO
124130723 12413072 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124130723 12413072 Anal incontinence
124130723 12413072 Aphasia
124130723 12413072 Arthralgia
124130723 12413072 Blood pressure increased
124130723 12413072 Cerebrovascular accident
124130723 12413072 Decreased appetite
124130723 12413072 Depression
124130723 12413072 Extremity contracture
124130723 12413072 Fatigue
124130723 12413072 Gastrointestinal haemorrhage
124130723 12413072 General physical health deterioration
124130723 12413072 Hyperaesthesia
124130723 12413072 Hypoaesthesia
124130723 12413072 Muscular weakness
124130723 12413072 Neuropathy peripheral
124130723 12413072 Off label use
124130723 12413072 Osteopenia
124130723 12413072 Pain in extremity
124130723 12413072 Paraesthesia
124130723 12413072 Peripheral swelling
124130723 12413072 Urinary incontinence
124130723 12413072 Urinary tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124130723 12413072 1 201503 2015 0
124130723 12413072 2 2015 20150506 0
124130723 12413072 3 20150629 0
124130723 12413072 4 2015 0